{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-073905","form_type":"8-K","ticker":null,"cik":"0001907685","company_name":"Comera Life Sciences Holdings, Inc.","filed_at":"2023-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.374370+00:00","generated_at":"2026-06-07T06:07:32.419099+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Comera Life Sciences raises $1.5M via 12% senior secured convertible notes due 2024 with warrants","bullets":["$1.5M aggregate principal of 12.0% Senior Secured Convertible Notes due Dec 29, 2024; convertible at $0.055/share, interest payable monthly.","Warrants issued for 200% of Note Shares, exercisable immediately at $0.055/share for 5 years.","Purchasers include existing major stockholders Charles Cherington and trusts controlled by David Soane (each >20% prior).","Purchasers granted Share Purchase right to buy all outstanding stock at $0.0825 or 1.5x closing price; exclusivity through Dec 2024.","Notes secured by first priority lien on substantially all assets; subject to affirmative/negative covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-073905","json":"https://secwatch.observer/filing/0000950170-23-073905.json","markdown":"https://secwatch.observer/filing/0000950170-23-073905.md","text":"https://secwatch.observer/filing/0000950170-23-073905.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907685/000095017023073905/0000950170-23-073905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907685/000095017023073905/cmra-20231229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:07:32.419099+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f9a1a795d203e61b880b8e426491a45b50aa5a37","claim":"Comera Life Sciences Holdings, Inc. incurred senior notes of $1,500,000 in aggregate principal amount with certain purchasers at 12.0% maturing December 29, 2024.","evidence_excerpt":"$1,500,000 in aggregate principal amount of 12.0% Senior Secured Convertible Notes due 2024","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1907685/000095017023073905/0000950170-23-073905-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$1,500,000 in aggregate principal amount"},{"label":"Counterparty","value":"certain purchasers"},{"label":"Rate","value":"12.0%"},{"label":"Maturity","value":"December 29, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"17ffc5e0eeb0abb50a942b4141ee02bab3e09b67","claim":"Comera Life Sciences Holdings, Inc. entered into Securities Purchase Agreement with certain purchasers valued at $1,500,000 (effective 2023-12-29).","evidence_excerpt":"On December 29, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain purchasers described below (collectively, the “Purchasers” and each, a “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the “Private Placement”) $1,500,000 in aggregate principal amount of 12.0% Senior Secured Convertible Notes due 2024","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1907685/000095017023073905/0000950170-23-073905-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain purchasers"},{"label":"Value","value":"$1,500,000"},{"label":"Effective","value":"2023-12-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}